ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

Hammer Signs $2.5 Mil. Check To NCI Fro Stop Cancer Campaign

February 2, 1990

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

NCI, CCSG Collaborating On Electromagnetic Field Exposure Study

April 6, 1990

Edward Harlow Returns to NCI As Special Assistant to Varmus

January 14, 2011

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994